News
Avelumab + sacituzumab govitecan (SG) vs avelumab monotherapy as first-line (1L) maintenance treatment in patients (pts) with advanced urothelial carcinoma (aUC): Interim analysis from the JAVELIN ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback